$1.32
-0.09-6.38%
Ult. Agg.: Oct 14, 7:56 PM
$1.36
-0.05-3.55%
Gain Therapeutics (GANX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.14 | $-0.14 | $-0.15 |
| Actual | $-0.11 | $-0.13 | $-0.11 | $-0.15 |
| Surprise | +26.7% | +7.14% | +21.4% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.11 | $-0.15 | 26.7 % |
| Q1 | May 11, 2026 | $-0.13 | $-0.14 | 7.14 % |
| Q4 | Mar 26, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q3 | Nov 12, 2025 | $-0.15 | $-0.15 | 0.00 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | May 14, 2025 | $0 | $33.33K | -100.0 % |
| Q4 | Mar 27, 2025 | $0 | $30.00K | -100.0 % |
| Q2 | Aug 8, 2024 | $0 | $400.00K | -100.0 % |
| Q1 | May 14, 2024 | $0 | $30.00K | -100.0 % |